@ARTICLE{
author={Oh Jiwon,Drulovic Jelena S,Dufek Michal,Budincevic Hrvoje,Habek Mario,Caunt Maresa,Cheng Ying-Fang,Harp Christopher,Sierzega Malgorzata,Clayton David,Ratchford John,Goodyear Alexandra,Bar-Or Amit},
year={2025},
title={Fenebrutinib maintains early and sustained low disease activity in patients with relapsing multiple sclerosis: 2-year results from the FENopta open-label extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={3},
pages={109-109},
document_type={Meeting Abstract},
}